Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

BofA ML downgrades Phoenix Group to 'neutral'

(Sharecast News) - Bank of America Merrill Lynch downgraded Phoenix Group on Thursday to 'neutral' form 'buy'. It said the shares have returned 32% year-to-date and it now only sees 13% total return potential, hence the downgrade.

The bank said Phoenix's new chief financial officer addressed its key issue - falling shareholders' equity - with full year results.

"He provided confidence that the dividend was sustainable and will grow progressively. But the yield no longer stands out versus peers," it said.

It said Phoenix's 8.5% 2025E dividend yield remains attractive and the third highest dividend yield in the FTSE 100 and that with 2.5% per annum growth ahead, Phoenix retains appeal.

"However, this yield must be seen in the context of a UK 10-year bond yield at 4.7%. The yield spread over the sovereign yield of 3.8% is in the bottom-half of European insurers. Phoenix's yield is also only the third highest in UK Life insurance and only around the same level as Aviva pro-forma for its Direct Line Group (DLG) acquisition if buybacks are also included."

BofA said Phoenix's declining shareholders' equity remains a concern for it, even after these concerns were addressed by the new CFO.

"Shareholders' equity is still set to decline until 2027E," it said. "The stock trades on 8.6x 2026E shareholders' equity, and even 1.8x 2026E total comprehensive equity. These multiples may raise concerns for some investors, even if the concerns are driven by accounting rather than economics."

The bank said that any increases in UK 10-15 year bond yields could further exacerbate concerns.

"Phoenix's new business growth has been phenomenal since the acquisition of Standard Life (SL) in 2018," it noted.

"Phoenix has grown from zero new business franchise to one of the fastest rates of contractual service margin (CSM) growth in the sector (6.7% CAGR 2024-27E). We expect growth to slightly slow but remain above sector average."

It added that potential rebranding of the group to Standard Life, as reported in the Financial Times, may help affirm perception that this is a growth company, but it thinks growth in shareholders' equity will also be required to build this confidence.

At 0930 BST, the shares were down 3% at 623p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.